Skip to content

Implementation of a Research Infrastructure Network to enable healthservice research in general practice in Baden-Wuerttemberg (FoPraNet-BW) - Observational study „Polymyalgia rheumatica“

Implementation of a Research Infrastructure Network to enable healthservice research in general practice in Baden-Wuerttemberg (FoPraNet-BW) - Observational study „Polymyalgia rheumatica“ - BEBOP PMR

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00032715
Enrollment
101
Registered
2023-11-08
Start date
2023-11-13
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M35.3 M31.5

Interventions

Group 1: Patients with prevalent polymyalgia rheumatica Retrospective disease data from patients with prevalent polymyalgia rheumatica who have signed the consent form are filtered from the practice m

Sponsors

Institut für Allgemeinmedizin und Interprofessionelle Versorgung
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. A confirmed (G) permanent diagnosis of polymyalgia rheumatica (ICD-10-GM codes: M35.3 polymyalgia rheumatica or M31.5 giant cell arteritis in polymyalgia rheumatica) and/or at least 2 confirmed diagnoses of polymyalgia rheumatica (no permanent diagnoses, ICD-10-GM codes: M35.3 polymyalgia rheumatica and/or M31.5 Giant cell arteritis in polymyalgia rheumatica) within the period from quarter III/2021 to quarter II/2023. 2. Age = 50 years at the time of data collection. 3. Ability to give consent, i.e. patient is able to assess the significance and scope of participation in the study or: in the absence of capacity to consent, written informed consent by the authorized person (e.g. guardian).

Exclusion criteria

Exclusion criteria: 1. Objection to the data processing for the identification of potential study participants in the practice management program within the framework of FoPraNet-BW 2. age <50 years at the time of data collection 3. no permanent diagnosis of polymyalgia rheumatica and/or fewer than two confirmed diagnoses (no permanent diagnosis) of polymyalgia rheumatica within the time period from quarter III/2021 to quarter II/2023 4. diagnosis of polymyalgia rheumatica not confirmed (suspected diagnosis (V), excluded diagnosis (A), or asymptomatic state following the diagnosis in question(Z)).

Design outcomes

Primary

MeasureTime frame
Feasability of reasearch in general pratice

Secondary

MeasureTime frame
Aspects of care in patients with prevalent polymyalgia rheumatica in general practice

Countries

Germany

Contacts

Public ContactStefanie Joos

Institut für Allgemeinmedizin und Interprofessionelle Versorgung

stefanie.joos@med.uni-tuebingen.de+497071 29 85213

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026